Abdollahian Neil

Chief Business OfficerBoundless Bio, Inc. (BOLD) · full profile →Form 4 · filed Aug 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2024Disposed to issuer(D)20K0
Aug 19, 2024Disposed to issuer(D)55K0
Aug 19, 2024Disposed to issuer(D)37K0
Aug 19, 2024Disposed to issuer(D)23K0
Aug 19, 2024Disposed to issuer(D)82K0
Aug 19, 2024Grant(A)20K20K
Aug 19, 2024Grant(A)55K55K
Aug 19, 2024Grant(A)37K37K
Aug 19, 2024Grant(A)23K23K
Aug 19, 2024Grant(A)82K82K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-099303) within minutes of acceptance. Every field above traces to the original document. Verify it directly: